boranes has been researched along with neuropeptide y in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck-Sickinger, AG; Frank, R; Hey-Hawkins, E; Hofmann, S; Schmidt, P | 1 |
| Ahrens, VM; Beck-Sickinger, AG; Bings, NH; Boehnke, S; Frank, R; Hampel, G; Hey-Hawkins, E; Iffland, DS; Schütz, CL | 1 |
| Beck-Sickinger, AG; Bellmann-Sickert, K; Hey-Hawkins, E; Hofmann, S; Lindner, J | 1 |
| Beck-Sickinger, AG; Els-Heindl, S; Hey-Hawkins, E; Hoppenz, P; Kellert, M; Köbberling, J; Kuhnert, R; Riedl, B; Saretz, S; Worm, DJ | 1 |
4 other study(ies) available for boranes and neuropeptide y
| Article | Year |
|---|---|
Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes.
Topics: Amino Acid Sequence; Animals; Boranes; Cells, Cultured; Chlorocebus aethiops; COS Cells; HEK293 Cells; Humans; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Neuropeptide Y; Protein Conformation; Receptors, Gastrointestinal Hormone; Structure-Activity Relationship | 2013 |
Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy.
Topics: Amino Acid Sequence; Animals; Boranes; Boron Neutron Capture Therapy; Breast Neoplasms; Chlorocebus aethiops; COS Cells; Female; HEK293 Cells; Humans; Molecular Sequence Data; Neuropeptide Y; Receptors, Neuropeptide Y | 2015 |
Carbaboranylation of Truncated C-Terminal Neuropeptide Y Analogue Leads to Full hY
Topics: Arrestin; Boranes; GTP-Binding Proteins; HEK293 Cells; Humans; Ligands; Models, Molecular; Neuropeptide Y; Peptides; Receptors, Neuropeptide Y; Signal Transduction | 2018 |
Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
Topics: Boranes; Boron; Boron Neutron Capture Therapy; Drug Carriers; Drug Delivery Systems; HEK293 Cells; Humans; MCF-7 Cells; Neoplasms; Neuropeptide Y; Receptors, Neuropeptide Y | 2020 |